Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-020862

EVP, Growth Markets Commercial sold 457 shares at $17.89 ($8,177)

  • EVP, Growth Markets Commercial acquired 872 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nazzi Gianfranco · EVP, Growth Markets Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-17 Exercise or conversion : show line 1 in the form +872 6,203.36 D
2018-03-19 Sale : show line 2 in the form −457 $17.89 $8,177 5,746.36 D
Open-market sales · 457 sh · avg $17.89 · $8,177

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-17 Exercise or conversion : show line 3 in the form Restricted Share Units −872 1,746 D
Loading xslF345X03/doc4.xml…